Herbalife stock price target reiterated at $21 by Texas Capital

Texas Capital Securities reiterated a Buy rating and $21 price target for Herbalife (HLF) after a facility tour and management meetings. The analyst highlighted the company's quality control, sales growth opportunities, and strong financial health. Herbalife reported Q3 2026 earnings of $0.64 per share and revenue of $1.35 billion, both exceeding expectations. The company also authorized a share repurchase program.

Original reporting
Published Nov 16, 2026, 10:32 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 16, 2026, 10:37 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$HLF
Neutral
high confidence
Mentioned
$HLF
Relevance
4/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$HLFNeutralLow
01

Why it matters

The reiteration reinforces existing bullish bias but adds no new data; investors may wait for further guidance or execution updates.

02

Market read

Recap of already‑public earnings and analyst target; low trading relevance.

03

What to watch

Potential impact of the share‑repurchase program could support price if execution details emerge.

Relevance 4/10Novelty 2/10Timing: none

Background

Herbalife (NYSE:HLF) reported Q3 2026 earnings two weeks ago, beating expectations. Texas Capital reiterated a $21 price target after a facility tour.

Company-level read

Ticker impact

$HLFNeutralHigh confidence
Context

Article recaps Herbalife's Q3 2026 earnings and analyst price target, which were already public 14 days earlier.

Expected impact

little to no immediate price movement expected

Evidence & confidence

The analyst reiterates a $21 target based on already‑released results; no fresh information to shift the market.

Market effects

None beyond existing health‑and‑wellness sector outlook.

No regional effect; Herbalife is a global consumer‑goods company.

Limited; article repeats known data.

Counterpoint

Without a fresh catalyst, the reiterated target may be overly optimistic if market sentiment turns negative.

Key entities

  • Herbalife Nutrition Ltd.

    Subject of the article; US‑listed consumer‑goods company.

  • Texas Capital Securities

    Provided the reiterated buy rating and price target.

Related articles

$HLFMedAI 8/10

Herbalife Ltd (HLF) (Q3 2026) Earnings Call Highlights: Fifth Straight Quarter

Herbalife (HLF) reported Q3 2026 net sales of $1.4B, up 6% YoY, and adjusted EBITDA of $182M, beating guidance. Growth was driven by India and nutrition clubs, while EMEA and China saw declines. The company raised full-year sales guidance but expects gradual margin expansion. Interim CEO John DeSimone discussed product repositioning and new technology platforms. Operating cash flow rose 27% YoY, and net leverage improved to 2.0x.

$HLFHighAI 8/10

Why Herbalife Stock Is Up Today

Herbalife (HLF) shares rose 8% after Q3 results showed 6% revenue growth to $1.35B, with Asia Pacific up 18%. Adjusted net income increased 33% to $68.5M. The company raised full-year sales guidance and announced a $250M stock buyback program. According to interim CEO John DeSimone, growth is driven by 3M+ independent distributors.

$HLFMedAI 8/10

Herbalife Reports Q3 2026 Financial Results

Herbalife Ltd. reported Q3 2026 net sales of $1.35B, up 6% YoY, with regional growth varying. Adjusted EBITDA was $182.4M, EPS $0.55. Gross margin slightly declined to 77.3%. The company cited refinancing benefits and debt reduction. Management expects continued net sales growth.

$HLFHighAI 8/10

Herbalife (HLF) Q3 2026 Earnings Call Transcript

Herbalife (HLF) reported Q3 2026 net sales of $1.4B, up 6% YoY, and adjusted EBITDA of $182M, exceeding guidance. Interim CEO John DeSimone highlighted growth opportunities, including strengthening Nutrition Clubs and expanding the Bioniq brand. The company aims to enhance distributor support and technology capabilities.

$HLFMedAI 8/10

What Herbalife (HLF) Said on Its Q3 Earnings Call

Herbalife (HLF) reported Q3 sales growth of 5.1% in constant currency and 9% reported, with North America up 1.7%. FX reduced net sales by $21M. The company outlined priorities: nutrition clubs, tech platforms, and Bioniq brand growth. It expects Q4 sales growth of 0.5% to 4.5% and raised full-year sales guidance to 4.9% to 5.9%. Operating cash flow rose 27% YoY to $298M.